Re:Biohackers take aim at big pharma’s stranglehold on insulin
by ska on Monday June 28, 2021 @05:38PM
(#27668532)
I understand that argument.I hadn't thought of the issue of insulin being a biologic, so true generics aren't likely, hence biosimilars. None of this justifies a 10x+ price increase on the same product over 20 years of course.
By the way that same site had an interesting article breaking down costs normalized by insulin unit
By that table and some assumptions about approx 40 IU/day it looks like the cheapest you could get away with at full retail would be about $120/mo, assuming optimal usage etc. The most expensive version would be at least 5x that.
By the way that same site had an interesting article breaking down costs normalized by insulin unit
https://www.goodrx.com/blog/how-much-does-insulin-cost-compa...
By that table and some assumptions about approx 40 IU/day it looks like the cheapest you could get away with at full retail would be about $120/mo, assuming optimal usage etc. The most expensive version would be at least 5x that.